Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.

Berthold, E

Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis. [electronic resource] - Scandinavian journal of rheumatology Jan 2018 - 22-26 p. digital

Publication Type: Journal Article

1502-7732

10.1080/03009742.2017.1290822 doi


Adult
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--blood
Enzyme-Linked Immunosorbent Assay
Etanercept--blood
Female
Follow-Up Studies
Humans
Male
Middle Aged
Tumor Necrosis Factor-alpha--blood